Cristina Venturini, UCL Department of Infection, Immunity & Inflamation
15 January 2025, 2:00 pm–3:00 pm

UGI Seminar: Cytomegalovirus genetic diversity and evolution: insights into genotypes and their role in viral pathogenesis.
Event Information
Open to
- All
Organiser
-
Marina Escalera Zamudio
UGI Seminar
Wednesday, 15 January @ 2pm
1-19 Torrington Place, G12 (map)
Cytomegalovirus genetic diversity and evolution: insights into genotypes and their role in viral pathogenesis
Abstract: Human cytomegalovirus (HCMV) is a ubiquitous virus that infects most of the human population and presents a wide range of phenotypes. While HCMV infections are typically asymptomatic in immunocompetent individuals, the virus is the leading infectious cause of congenital disabilities and can cause severe or fatal diseases in immunocompromised individuals. The high genetic variability among HCMV strains, coupled with frequent reinfection and recombination, poses significant challenges for the development of effective vaccines.
In this talk, I will present an analysis of the genomic landscape of HCMV. Genetic differences among HCMV strains span the entire genome, with certain regions exhibiting markedly higher variability. These "hypervariable" or "multi-allelic" regions are of particular interest due to their potential role in viral adaptation and immune evasion. To precisely define the boundaries of these regions and quantify their allelic diversity, we applied a hidden Markov Model (HMM) approach to 253 publicly available HCMV genomes. This analysis revealed distinct evolutionary patterns: while much of the genome is shaped by geographically linked founder effects, some hypervariable regions display evidence of balancing selection, suggesting selective pressures that maintain allele diversity across populations, regardless of geographic origin.
These findings raise critical questions about the functional significance of HCMV genomic variation. Are specific genetic differences associated with distinct biological phenotypes or clinical outcomes? Understanding these links could illuminate how viral diversity influences disease progression and immune response, ultimately guiding the design of more targeted interventions, including vaccines and therapeutics.
About the Speaker
Cristina Venturini
at UCL Department of Infection, Immunity & Infection
I’m a research fellow at the Infection, Immunity and Inflammation, Great Ormond Street Institute of Child Health. I am a computational geneticist exploring why people respond differently to the same viral infections. My work focuses on congenital and paediatric diseases, combining human and viral genomics to unravel the complex interplay of genetics and environment in shaping disease outcomes.
During my PhD at UCL and KCL, I became an expert in statistical genetics, working on glaucoma and blood pressure in different populations. Afterwards, I joined UCL’s Infection & Immunity division, where I investigated how our immune system fights infections like chickenpox and tuberculosis. Using RNA sequencing, I uncovered unique patterns that reveal how the body reacts to these infections.
More recently, I’ve turned my attention to herpesviruses. I’ve identified viral deletions in Epstein-Barr virus linked to severe disease and discovered a genetic signature in cytomegalovirus that predicts poor outcomes after transplant. My ultimate goal is to connect the dots between human and viral genetics to provide better treatment and patient outcomes worldwide.
More about Cristina Venturini